GKB Ophthalmics Ltd.
NSE: GKB | BSE: 533212
₹60.00
₹-0.98
(-1.61%)
As on 10-Jul-2026IST
Market cap
₹30 Cr
Revenue (TTM)
₹149 Cr
P/E Ratio
24.8
P/B Ratio
0.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
-12.7 %
-
ROCE
-6.3 %
-
Industry P/E
39.65
-
EV/EBITDA
3.4
-
Debt to Equity
0
-
Book Value
₹104.8
-
EPS
₹2.9
-
Face value
10
-
Shares outstanding
5,040,580
10 Years Aggregate
CFO
₹-0.39 Cr
EBITDA
₹12.96 Cr
Net Profit
₹-6.85 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
GKB Ophthalmics
| 17.1 | -4.6 | -14.2 | -19.0 | -13.3 | -10.1 | -1.1 |
|
BSE Healthcare
| 15.0 | 5.8 | 17.8 | 12.3 | 24.4 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
GKB Ophthalmics
| -47.7 | -2.8 | -9.6 | 27.5 | 12.9 | 37.7 | -56.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
GKB Ophthalmics
|
60.0 | 30.2 | 149.1 | 3.1 | 3.4 | 2.8 | 24.8 | 0.6 |
| 80.0 | 29.2 | 53.8 | -2.2 | 2.0 | -7.5 | -- | 1.1 | |
| 2,479.4 | 40,877.0 | 6,430.7 | 1,027.3 | 18.8 | 10.5 | 39.8 | 3.9 | |
| 219.8 | 1,209.2 | 277.9 | 26.4 | 9.9 | 8.3 | 41.7 | 5.0 | |
| 826.1 | 9,922.7 | 6,892.5 | 219.6 | 4.7 | 11.5 | 45.2 | 5.0 | |
| 20.9 | 11.5 | 7.9 | 0.7 | 12.2 | 46.1 | 15.6 | 6.4 | |
| 1,668.3 | 16,865.7 | 1,875.3 | 315.1 | 17.4 | 10.9 | 52.4 | 5.4 | |
| 152.1 | 56.6 | 21.6 | 3.2 | 20.8 | 18.6 | 18 | 3.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About GKB Ophthalmics
There is no Profile data available for GKB.NS.
-
Incorporated
1981
-
Chairman
KG Gupta
-
Managing Director
KG Gupta
-
Group
GKB
-
Headquarters
Mapusa, Goa
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for GKB Ophthalmics
What is the current share price of GKB Ophthalmics Ltd Today?
The share price of GKB Ophthalmics Ltd is ₹60.00 (BSE) and ₹84.05 (NSE) as of 10-Jul-2026 IST. GKB Ophthalmics Ltd has given a return of -13.28% in the last 3 years.
What is the current PB & PE ratio of GKB Ophthalmics Ltd?
The P/E ratio of GKB Ophthalmics Ltd is 24.83 times as on 10-Jul-2026, a 37 discount to its peers’ median range of 39.65 times.
The P/B ratio of GKB Ophthalmics Ltd is 0.57 times as on 10-Jul-2026, a 85 discount to its peers’ median range of 3.93 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.58
|
|
2024
|
0.00
|
0.74
|
|
2023
|
0.00
|
0.87
|
|
2022
|
36.39
|
0.73
|
|
2021
|
0.00
|
0.66
|
What is the 52 Week High and Low of GKB Ophthalmics Ltd?
The 52-week high and low of GKB Ophthalmics Ltd are Rs 91.70 and Rs 45.25 as of 10-Jul-2026.
What is the market cap of GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd has a market capitalisation of ₹ 30 Cr as on 10-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in GKB Ophthalmics Ltd?
Before investing in GKB Ophthalmics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.